Cargando…

Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis

Background and Objectives: Transaxillary access is a straightforward “single incision—direct vision” concept, based on a 5 cm skin incision in the right anterior axillary line. It is suitable for aortic, mitral and tricuspid surgery. The present study evaluates the hospital outcomes of the transaxil...

Descripción completa

Detalles Bibliográficos
Autores principales: Taghizadeh-Waghefi, Ali, Arzt, Sebastian, De Angelis, Veronica, Schiffarth, Jana, Petrov, Asen, Tomko, Matuš, Alexiou, Konstantin, Matschke, Klaus, Kappert, Utz, Wilbring, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785245/
https://www.ncbi.nlm.nih.gov/pubmed/36557053
http://dx.doi.org/10.3390/medicina58121850
_version_ 1784858002164023296
author Taghizadeh-Waghefi, Ali
Arzt, Sebastian
De Angelis, Veronica
Schiffarth, Jana
Petrov, Asen
Tomko, Matuš
Alexiou, Konstantin
Matschke, Klaus
Kappert, Utz
Wilbring, Manuel
author_facet Taghizadeh-Waghefi, Ali
Arzt, Sebastian
De Angelis, Veronica
Schiffarth, Jana
Petrov, Asen
Tomko, Matuš
Alexiou, Konstantin
Matschke, Klaus
Kappert, Utz
Wilbring, Manuel
author_sort Taghizadeh-Waghefi, Ali
collection PubMed
description Background and Objectives: Transaxillary access is a straightforward “single incision—direct vision” concept, based on a 5 cm skin incision in the right anterior axillary line. It is suitable for aortic, mitral and tricuspid surgery. The present study evaluates the hospital outcomes of the transaxillary access for isolated mitral valve surgery compared with full sternotomy. Patients and Methods: The final study group included 480 patients. A total of 160 consecutive transaxillary patients served as treatment group (MICS-MITRAL). Based on a multivariate logistic regression model including age, sex, body-mass-index, EuroScore II and LVEF, a 1:2 propensity matched control-group (n = 320) was generated out of 980 consecutive sternotomy patients. Redo surgeries, endocarditis or combined procedures were excluded. The mean age was 66.6 ± 10.6 years, 48.6% (n = 234) were female. EuroSCORE II averaged 1.98 ± 1.4%. Results: MICS-MITRAL had longer perfusion (88.7 ± 26.6 min vs. 68.7 ± 32.7 min; p < 0.01) and cross-clamp (64.4 ± 22.3 min vs. 49.7 ± 22.4 min; p < 0.01) times. This did not translate into longer procedure times (132 ± 31 min vs. 131 ± 46 min; p = 0.76). Both groups showed low rates of failed repair (MICS-MITRAL: n = 6/160; 3.75%; Sternotomy: n = 10/320; 3.1%; p = 0.31). MICS-MITRAL had lower transfusion rates (p ≤ 0.001), less re-exploration for bleeding (p = 0.04), shorter ventilation times (p = 0.02), shorter ICU-stay (p = 0.05), less postoperative hemofiltration (p < 0.01) compared to sternotomy patients. No difference was seen in the incidence of stroke (p = 0.47) and postoperative delirium (p = 0.89). Hospital mortality was significantly lower in MICS-MITRAL patients (0.0% vs. 3.4%; p = 0.02). Conclusions: The transaxillary access for MICS-MITRAL provides superior cosmetics and excellent clinical outcomes. It can be performed at least as safely and in the same time frame as conventional mitral surgery by sternotomy.
format Online
Article
Text
id pubmed-9785245
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97852452022-12-24 Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis Taghizadeh-Waghefi, Ali Arzt, Sebastian De Angelis, Veronica Schiffarth, Jana Petrov, Asen Tomko, Matuš Alexiou, Konstantin Matschke, Klaus Kappert, Utz Wilbring, Manuel Medicina (Kaunas) Article Background and Objectives: Transaxillary access is a straightforward “single incision—direct vision” concept, based on a 5 cm skin incision in the right anterior axillary line. It is suitable for aortic, mitral and tricuspid surgery. The present study evaluates the hospital outcomes of the transaxillary access for isolated mitral valve surgery compared with full sternotomy. Patients and Methods: The final study group included 480 patients. A total of 160 consecutive transaxillary patients served as treatment group (MICS-MITRAL). Based on a multivariate logistic regression model including age, sex, body-mass-index, EuroScore II and LVEF, a 1:2 propensity matched control-group (n = 320) was generated out of 980 consecutive sternotomy patients. Redo surgeries, endocarditis or combined procedures were excluded. The mean age was 66.6 ± 10.6 years, 48.6% (n = 234) were female. EuroSCORE II averaged 1.98 ± 1.4%. Results: MICS-MITRAL had longer perfusion (88.7 ± 26.6 min vs. 68.7 ± 32.7 min; p < 0.01) and cross-clamp (64.4 ± 22.3 min vs. 49.7 ± 22.4 min; p < 0.01) times. This did not translate into longer procedure times (132 ± 31 min vs. 131 ± 46 min; p = 0.76). Both groups showed low rates of failed repair (MICS-MITRAL: n = 6/160; 3.75%; Sternotomy: n = 10/320; 3.1%; p = 0.31). MICS-MITRAL had lower transfusion rates (p ≤ 0.001), less re-exploration for bleeding (p = 0.04), shorter ventilation times (p = 0.02), shorter ICU-stay (p = 0.05), less postoperative hemofiltration (p < 0.01) compared to sternotomy patients. No difference was seen in the incidence of stroke (p = 0.47) and postoperative delirium (p = 0.89). Hospital mortality was significantly lower in MICS-MITRAL patients (0.0% vs. 3.4%; p = 0.02). Conclusions: The transaxillary access for MICS-MITRAL provides superior cosmetics and excellent clinical outcomes. It can be performed at least as safely and in the same time frame as conventional mitral surgery by sternotomy. MDPI 2022-12-15 /pmc/articles/PMC9785245/ /pubmed/36557053 http://dx.doi.org/10.3390/medicina58121850 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Taghizadeh-Waghefi, Ali
Arzt, Sebastian
De Angelis, Veronica
Schiffarth, Jana
Petrov, Asen
Tomko, Matuš
Alexiou, Konstantin
Matschke, Klaus
Kappert, Utz
Wilbring, Manuel
Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis
title Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis
title_full Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis
title_fullStr Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis
title_full_unstemmed Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis
title_short Safety and Efficacy of the Transaxillary Access for Minimally Invasive Mitral Valve Surgery—A Propensity Matched Competitive Analysis
title_sort safety and efficacy of the transaxillary access for minimally invasive mitral valve surgery—a propensity matched competitive analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785245/
https://www.ncbi.nlm.nih.gov/pubmed/36557053
http://dx.doi.org/10.3390/medicina58121850
work_keys_str_mv AT taghizadehwaghefiali safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT arztsebastian safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT deangelisveronica safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT schiffarthjana safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT petrovasen safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT tomkomatus safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT alexioukonstantin safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT matschkeklaus safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT kappertutz safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis
AT wilbringmanuel safetyandefficacyofthetransaxillaryaccessforminimallyinvasivemitralvalvesurgeryapropensitymatchedcompetitiveanalysis